Colossal Biosciences made a surprise announcement Monday, claiming it had brought the dire wolf back from the dead, achieving ...

the former Genentech chief scientific officer and Denali Therapeutics co-founder who last year resigned as Stanford University president after findings of research manipulation in his lab.

A prominent genetics professor at Stanford University in the US has paid $29 million to investors in Nuredis – a biotech that has now been wound up – after a California court found he ...

Stanford University genetics professor Dr. Stanley Cohen paid $29.2 million to settle a lawsuit over misleading claims he made about Nuredis Inc., his now-dissolved biotechnology company.

Bo Wang is a renowned AI scientist at the University of Toronto. He’s bringing his open-source culture and computational ...

The broad field of biotechnology and applied microbiology covers topics on the manipulation of living organisms to make products or solve problems to meet human needs. Students in this field study ...

Denali Therapeutics is advancing the fight against neurodegenerative diseases thanks to pioneering work in methods to carry ...

Nicole Paulk, Ph.D., never planned to be a CEO. As a UCSF gene therapy professor, she envisioned a lifelong academic career — ...

Airna will use the Series B round to launch a Phase 1/2 trial of its lead program for alpha-1 antitrypsin deficiency, a disease targeted by several other firms.